# Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects

> **NCT02578953** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 36 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Dutasteride-Test product
- **DRUG:** Dutasteride-Reference product

## Key facts

- **NCT ID:** NCT02578953
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-09
- **Primary completion:** 2015-12-15
- **Final completion:** 2015-12-15
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02578953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02578953, "Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02578953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*